Literature DB >> 33213391

COVID-19 mortality risk for older men and women.

N David Yanez1, Noel S Weiss2, Jacques-André Romand3, Miriam M Treggiari4.   

Abstract

BACKGROUND: Case-fatality from COVID-19 has been reported to be relatively high in patients age 65 years or older. We sought to determine the age-specific rates of COVID-19 mortality at the population level.
METHODS: We obtained information regarding the total number of COVID-19 reported deaths for six consecutive weeks beginning at the 50th recorded death, among 16 countries that reported a relatively high number of COVID-19 cases as of April 12, 2020. We performed an ecological study to model COVID-19 mortality rates per week by age group (54 years or younger, 55-64 years, and 65 years or older) and sex using a Poisson mixed effects regression model.
RESULTS: Over the six-week period of data, there were 178,568 COVID-19 deaths from a total population of approximately 2.4 billion people. Age and sex were associated with COVID-19 mortality. Compared with individuals ages 54 years or younger, the incident rate ratio (IRR) was 8.1, indicating that the mortality rate of COVID-19 was 8.1 times higher (95%CI = 7.7, 8.5) among those 55 to 64 years, and more than 62 times higher (IRR = 62.1; 95%CI = 59.7, 64.7) among those ages 65 or older. Mortality rates from COVID-19 were 77% higher in men than in women (IRR = 1.77, 95%CI = 1.74, 1.79).
CONCLUSIONS: In the 16 countries examined, persons age 65 years or older had strikingly higher COVID-19 mortality rates compared to younger individuals, and men had a higher risk of COVID-19 death than women.

Entities:  

Keywords:  Age; Pandemic; Population health; Severe acute respiratory syndrome-CoronaVirus-2, epidemiology

Mesh:

Year:  2020        PMID: 33213391      PMCID: PMC7675386          DOI: 10.1186/s12889-020-09826-8

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


Background

After the emergence of a novel coronavirus (Severe Acute Respiratory Syndrome-CoronaVirus-2 [SARS-CoV-2]) in China, a pandemic has spread worldwide [1]. Clinical manifestations of SARS-CoV-2 infection have been designated as COVID-19. The epidemic that originated in the Hubei province in China spread to over 60 countries, with western Europe and the US being particularly severely affected by COVID-19. Data from China and Italy suggest a case-fatality of 2.3% in patients with COVID-19, with more than 50% of the fatalities occurring in patients 50 years of age or older [2]. In the largest reported series from Northern Italy, case-fatality in patients 64 years or older was 36% compared with 15% in younger patients [3]. The mortality rate from COVID-19 in any age category is determined not only by the case-fatality among recognized incident cases, but by the age-specific incidence itself. Using age-specific mortality data, we sought to determine the relative risk of death across age categories in 16 countries that have had a high reported incidence of COVID-19 .

Methods

Tabulations of COVID-19 deaths were obtained from the 21 countries with the highest recorded number of cases of COVID-19 as of April 12, 2020. Our data source for COVID-19 cases and deaths was the Johns Hopkins University, Center for Systems Science and Engineering Coronavirus Resource Center (CSSE). CSSE provides numbers of deaths and confirmed cases for each country across the globe [4]. The countries in our sample were (in alphabetical order): Austria, Belgium, Brazil, Canada, China, France, Germany, India, Iran, Israel, Italy, Netherlands, Portugal, Russia, South Korea, Spain, Sweden, Switzerland, Turkey, the United Kingdom, and the United States. We collected the total number of deaths each country over 6 weeks starting the day of a country’s fiftieth recorded COVID-19 death. On May 8, 2020, complete 6-weeks of data were available for 19 of the 21 countries. Age and sex distributions for COVID-19 deaths were procured for 16 of the 19 countries, predominantly from government ministries of public health. We estimated the number of COVID-19 deaths for each age and sex group for the 6-week totals of COVID-19 deaths for each country. COVID-19 mortality rates were determined using age and sex specific population sizes for each country using 2020 population estimates from the Central Intelligence Agency (CIA) World Factbook [5]. Table 1 provides variable definitions, all publicly available data sources, their provenance, and weblinks where these data can be extracted.
Table 1

Data Sources

VariablesSourceData
COVID-19 DeathsJohns Hopkins University the Center for Systems Science and Engineering (CSSE) Coronavirus Resource Center coronavirus.jhu.eduCountry level COVID-19 deaths up to May 8, 2020.
Age groups, sex, population sizes by age and sexCIA World Factbookcia.gov/library/publications/the-world-factbookCountry-level population sizes (2020 est.) and demographic factors.
COVID-19 deaths by age and sex

info.gesundheitsministerium.at (AUT)

info-coronavirus.be (BEL)

covid.saude.gov.br (BRA)

wikipedia.org/wiki/COVID-19_pandemic_in_Canada (CAN)

qbitai.com/2020/02/11611.html (CHN)

statista.com/statistics/1110092/coronavirus-covid-19-deaths-age-group-switzerland/ (CH)

Robert Koch Institute (DEU)

mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_96_COVID-19.pdf (ESP)

santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/documents/bulletin-national/covid-19-point-epidemiologique-du-15-mars-2020 (FRA)

statista.com/statistics/1105061/coronavirus-deaths-by-region-in-italy (ITA)

ncov.mohw.go.kr (KOR)

rivm.nl/coronavirus-covid-19/grafieken (NLD)

wikipedia.org/wiki/COVID-19_pandemic_in_Portugal (POR)

statista.com/statistics/1107913/number-of-coronavirus-deaths-in-sweden-by-age-groups (SWE)

www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/weekending17april2020 (UK)

www.cdc.gov/nchs/nvss/vsrr/covid_weekly (USA)

Joint distributions for BEL, ESP, DEU, KOR, NLD, POR, UK; marginal distributions for others.
Data Sources info.gesundheitsministerium.at (AUT) info-coronavirus.be (BEL) covid.saude.gov.br (BRA) wikipedia.org/wiki/COVID-19_pandemic_in_Canada (CAN) qbitai.com/2020/02/11611.html (CHN) statista.com/statistics/1110092/coronavirus-covid-19-deaths-age-group-switzerland/ (CH) Robert Koch Institute (DEU) mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_96_COVID-19.pdf (ESP) santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/documents/bulletin-national/covid-19-point-epidemiologique-du-15-mars-2020 (FRA) statista.com/statistics/1105061/coronavirus-deaths-by-region-in-italy (ITA) ncov.mohw.go.kr (KOR) rivm.nl/coronavirus-covid-19/grafieken (NLD) wikipedia.org/wiki/COVID-19_pandemic_in_Portugal (POR) statista.com/statistics/1107913/number-of-coronavirus-deaths-in-sweden-by-age-groups (SWE) www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/weekending17april2020 (UK) www.cdc.gov/nchs/nvss/vsrr/covid_weekly (USA)

Statistical methods

We performed an ecological study to model the association between COVID-19 mortality as the outcome versus age and sex using a multilevel mixed-effects Poisson regression model. The predictor of particular interest, age, was categorized as: 0 to 54, 55 to 64 and 65 or older years. We modeled COVID-19 deaths (Deaths) as. where E[Death | Age, Sex] denotes the mean number of COVID-19 deaths by age (Age) and sex (Sex) groups. We incorporated a normal, mean zero country-level random effect, b; to account for correlated data at the country level. The model indices denote the country (i = 1,2,…,16), age groups (j = 1 ages [≤ 54 years], 2 ages [55–64 years], 3 ages [≥ 65 years]) and sex (k = 1 for female, k = 0 for male); the country population sizes by age and gender groups, N, were modeled as an offset. The exponentiated regression coefficients are interpreted as incidence rate ratios (IRR’s) of COVID-19 mortality. Six-week total COVID-19 deaths were disaggregated for each country using their respective estimated age and sex distributions of COVID-19 deaths. Our analyses accounted for this source of variation using a non-parametric bootstrap procedure. We selected 10,000 bootstrap samples from the estimated age and sex distributions of COVID-19 deaths to generate 10,000 disaggregated estimates of the COVID-19 death totals by age and sex for each country. Bootstrap standard errors were used in testing whether there were differences in the COVID-19 mortality rates between age groups and for sex. Specifically, Wald statistics were used to test for associations between the age groups and for sex. We provide 95% bootstrapped confidence intervals using the tolerance interval method on the 10,000 bootstrap estimates. Analyses were conducted using the Stata statistical package (StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp LP).

Results

Of the 178,568 COVID-19 deaths reported in our six-week sample from a total population of approximately 2.4 billion people, 153,923 deaths (86.2%) were in persons age 65 years or older. Table 2 presents the cumulative number of COVID-19 deaths and COVID-19 mortality rates (per week per million persons) for the six specified age and sex categories. Figure 1 displays actual and estimated weekly number of COVID-19 deaths. The United States had the highest number of COVID-19 deaths per week, followed by several of the western European countries initially affected by COVID-19. Figure 2 shows actual and model estimated weekly averaged COVID-19 mortality rates for the three age groups, stratified by sex. We observed that eight of the 11 western European countries in our sample had the highest mortality rates, followed by the three countries in the Americas (US, Canada, Brazil) and then German and Austria. China and South Korea had the lowest COVID-19 mortality rates among the countries in our sample. By age groups, we see that the mortality rates and model estimates clearly show COVID-19 mortality rates have been higher in the older age categories.
Table 2

Total deaths and death rates per week per million stratified by age and sex

CountryOverallWomenMen
0–5455–6465+0–5455–6465+
Austria
Population (mil.)8.92.90.61.02.90.60.8
Total deaths55149230511292
Death rate10.40.22.538.30.33.160.8
Belgium
Population (mil.)11.73.90.81.34.00.81.0
Total deaths7636171543453153483649
Death rate108.80.732.1442.70.672.5608.2
Brazil
Population (mil.)212.085.410.911.286.19.88.3
Total deaths787937544123365626613504
Death rate6.20.76.734.81.111.270.4
Canada
Population (mil.)37.712.42.73.912.82.63.3
Total deaths44872553191632662395
Death rate19.80.33.381.90.44.2121.0
China
Population (mil.)1390504.483.690.5549.284.881.6
Total deaths30161372337162434141273
Death rate0.40.00.51.30.10.82.6
France
Population (mil.)67.822.44.47.923.14.16.0
Total deaths21,746391304800358745712,004
Death rate53.52.911.5168.84.218.6333.4
Germany
Population (mil.)80.224.36.310.324.96.38.1
Total deaths6556459927191323023259
Death rate13.60.32.644.00.98.067.1
Italy
Population (mil.)62.420.04.57.819.94.25.9
Total deaths19,847208513622538695311,562
Death rate53.01.719.0133.03.237.8326.6
Korea, South
Population (mil.)51.817.14.14.718.53.93.6
Total deaths182497351082
Death rate0.60.00.42.60.00.43.8
Netherlands
Population (mil.)17.35.71.21.95.81.21.6
Total deaths450827601867371402377
Death rate43.40.88.3163.81.119.4247.6
Portugal
Population (mil.)10.33.40.71.33.40.60.9
Total deaths102910214931740449
Death rate16.70.55.063.20.811.183.1
Spain
Population (mil.)50.016.73.35.317.63.24.0
Total deaths21,228224372821544989011,078
Death rate70.82.218.8258.34.346.4461.6
Sweden
Population (mil.)10.23.40.61.13.50.61.0
Total deaths27923966109652871453
Death rate45.61.918.3166.12.524.2242.2
Switzerland
Population (mil.)8.42.80.60.92.90.60.7
Total deaths168310336641445917
Death rate33.40.69.2123.00.812.5218.3
United Kingdom
Population (mil.)65.822.14.26.7234.15.5
Total deaths23,9905924778605107189912,345
Death rate60.84.518.9214.17.736.5374.1
United States
Population (mil.)333.0115.622.131.0118.220.725.0
Total deaths51,4351783276517,1862436377923,487
Death rate25.72.620.992.43.430.4156.6
Fig. 1

COVID-19 actual and estimated average number of weekly deaths for six consecutive weeks beginning with the 50th recorded death, among 16 countries that reported a relatively high number of COVID-19 cases as of April 12, 2020. Part A women, Part B men

Fig. 2

COVID-19 actual and estimated weekly death rates for six consecutive weeks beginning with the 50th recorded death, among 16 countries that reported a relatively high number of COVID-19 cases as of April 12, 2020. Part A women, Part B men

Total deaths and death rates per week per million stratified by age and sex COVID-19 actual and estimated average number of weekly deaths for six consecutive weeks beginning with the 50th recorded death, among 16 countries that reported a relatively high number of COVID-19 cases as of April 12, 2020. Part A women, Part B men COVID-19 actual and estimated weekly death rates for six consecutive weeks beginning with the 50th recorded death, among 16 countries that reported a relatively high number of COVID-19 cases as of April 12, 2020. Part A women, Part B men We observed COVID-19 mortality rates for women in Fig. 2 (a) to be uniformly lower compared to the rates for men, Fig. 2 (b). Estimates for our formal analysis compared COVID-19 mortality rates by age group and sex. We observed that individuals ages 55 to 64 years had 8.1 times higher COVID-19 mortality rate than individuals younger than 55 years of age (IRR = 8.1, 95% CI = 7.7, 8.5), and that those age 65 or older had a 62 times higher rate compared to the youngest group (IRR = 62.1, 95%CI = 59.7, 64.7). Persons age 65 or older had 7.7 times higher COVID-19 death rates than those between the ages of 55 and 64 years (IRR = 7.7, 95%CI = 7.4, 7.9). Finally, we observed that men had 1.77 times higher COVID-19 mortality rates than did women (IRR = 1.77, 95% CI = 1.74, 1.79).

Discussion

In this study of COVID-19 in 16 countries, we found that COVID-19 mortality rates were strongly associated with older age and (to a lesser extent) with sex, with men having 77% higher mortality. Estimated IRRs were highest in the elderly. These observations suggest that the previously observed high COVID-19 case-fatality among older persons translates into a similarly high mortality rate at the population level. Although case fatality rates have been initially reported to be similar across countries [2], they have been subsequently found to vary significantly among countries. Several factors may contribute to these differences including type of healthcare systems, patient characteristics, or prevalence of diagnostic testing [6]. Patient comorbidities such as hypertension, diabetes, and obesity have been shown to be associated with higher COVID-19 mortality [7]. Since the number of comorbid conditions steadily increases with age, this could be another logical explanation of the observed increased mortality in older patients. While disease mortality is higher in the elderly in other conditions like cardiovascular disease, changes associated with immunsenscence might explain the increased vulnerability to infection and the disproportionately high mortality due to COVID-19 in older patients [6]. Consistent with our findings, in a recent meta-analysis of all-cause mortality from four countries (China, Italy, Spain, United Kingdom), and New York State, the percentage of octogenarians was found to be different across the regions with the lowest cohort being in China and the highest in New York State. Similarly, the lowest mortality was observed in China (3.1%) and the highest in New York State (21%) [8]. The largest increase in mortality risk was observed in patients aged 60 to 69 years. Therefore, it is important to report age-specific rates of COVID-19 mortality that account for these sources of variability in the population. While determining the incidence of COVID-19 in a given population depends in part on the prevalence and quality of testing for the presence of this infection, reporting of mortality should be less affected by these factors. Nonetheless, COVID-19 deaths will have been underreported to the extent that persons may die without being identified as positive for SARS CoV-2. To the extent that this underascertainment of COVID-19 mortality is relatively greater in the elderly, we would have underestimated the magnitude of the relative mortality rate among persons in this age group. However, we recognize that the major limitations of this study is related to the possible differences in reporting of attributable deaths across countries, which would affect the rates reported by each country. Another limitation is the lack of available data on confounding factors e.g. ethnicity and patient co-morbidities known to be risk factors for COVID-19 mortality [9-11].

Conclusions

As policy-makers prepare to make decisions on how to curb the outbreak, while reducing the pressures on the healthcare system and reopening the economy, it will be important that future choices be tailored to account for the demographics of the population and specifically consider the prevalence of people ager 65 or older in the population in specific regions [12], or communities in which nursing homes are located [13, 14]. Within countries, mapping of regional age distribution potentially could help identify areas at particularly high risk of being affected [15]. At a more granular level, tracking older population dynamics and interactions may provide further guidance on how to protect the more vulnerable older population.
  12 in total

1.  What Other Countries Can Learn From Italy During the COVID-19 Pandemic.

Authors:  Stefania Boccia; Walter Ricciardi; John P A Ioannidis
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

2.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.

Authors:  Giacomo Grasselli; Alberto Zangrillo; Alberto Zanella; Massimo Antonelli; Luca Cabrini; Antonio Castelli; Danilo Cereda; Antonio Coluccello; Giuseppe Foti; Roberto Fumagalli; Giorgio Iotti; Nicola Latronico; Luca Lorini; Stefano Merler; Giuseppe Natalini; Alessandra Piatti; Marco Vito Ranieri; Anna Mara Scandroglio; Enrico Storti; Maurizio Cecconi; Antonio Pesenti
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

3.  Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.

Authors:  Rossella Porcheddu; Caterina Serra; David Kelvin; Nikki Kelvin; Salvatore Rubino
Journal:  J Infect Dev Ctries       Date:  2020-02-29       Impact factor: 0.968

Review 4.  Research with older people in a world with COVID-19: identification of current and future priorities, challenges and opportunities.

Authors:  Sarah J Richardson; Camille B Carroll; Jacqueline Close; Adam L Gordon; John O'Brien; Terence J Quinn; Lynn Rochester; Avan A Sayer; Susan D Shenkin; Nathalie van der Velde; Jean Woo; Miles D Witham
Journal:  Age Ageing       Date:  2020-10-23       Impact factor: 10.668

5.  Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States.

Authors:  Z Imam; F Odish; I Gill; D O'Connor; J Armstrong; A Vanood; O Ibironke; A Hanna; A Ranski; A Halalau
Journal:  J Intern Med       Date:  2020-06-22       Impact factor: 13.068

Review 6.  Age-Related Morbidity and Mortality among Patients with COVID-19.

Authors:  Seung Ji Kang; Sook In Jung
Journal:  Infect Chemother       Date:  2020-06-12

7.  The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects.

Authors:  Clara Bonanad; Sergio García-Blas; Francisco Tarazona-Santabalbina; Juan Sanchis; Vicente Bertomeu-González; Lorenzo Fácila; Albert Ariza; Julio Núñez; Alberto Cordero
Journal:  J Am Med Dir Assoc       Date:  2020-05-25       Impact factor: 4.669

8.  Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.

Authors:  Temet M McMichael; Dustin W Currie; Shauna Clark; Sargis Pogosjans; Meagan Kay; Noah G Schwartz; James Lewis; Atar Baer; Vance Kawakami; Margaret D Lukoff; Jessica Ferro; Claire Brostrom-Smith; Thomas D Rea; Michael R Sayre; Francis X Riedo; Denny Russell; Brian Hiatt; Patricia Montgomery; Agam K Rao; Eric J Chow; Farrell Tobolowsky; Michael J Hughes; Ana C Bardossy; Lisa P Oakley; Jesica R Jacobs; Nimalie D Stone; Sujan C Reddy; John A Jernigan; Margaret A Honein; Thomas A Clark; Jeffrey S Duchin
Journal:  N Engl J Med       Date:  2020-03-27       Impact factor: 91.245

9.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.

Authors:  Wei-Jie Guan; Wen-Hua Liang; Yi Zhao; Heng-Rui Liang; Zi-Sheng Chen; Yi-Min Li; Xiao-Qing Liu; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Chun-Quan Ou; Li Li; Ping-Yan Chen; Ling Sang; Wei Wang; Jian-Fu Li; Cai-Chen Li; Li-Min Ou; Bo Cheng; Shan Xiong; Zheng-Yi Ni; Jie Xiang; Yu Hu; Lei Liu; Hong Shan; Chun-Liang Lei; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Lin-Ling Cheng; Feng Ye; Shi-Yue Li; Jin-Ping Zheng; Nuo-Fu Zhang; Nan-Shan Zhong; Jian-Xing He
Journal:  Eur Respir J       Date:  2020-05-14       Impact factor: 16.671

10.  Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-17       Impact factor: 17.586

View more
  126 in total

Review 1.  A review on the COVID-19-related psychological impact on older adults: vulnerable or not?

Authors:  Eleni Parlapani; Vasiliki Holeva; Vasiliki Aliki Nikopoulou; Stergios Kaprinis; Ioannis Nouskas; Ioannis Diakogiannis
Journal:  Aging Clin Exp Res       Date:  2021-05-17       Impact factor: 3.636

2.  Higher 90-Day Mortality after Surgery for Hip Fractures in Patients with COVID-19: A Case-Control Study from a Single Center in Italy.

Authors:  Alberto Grassi; Luca Andriolo; Davide Golinelli; Dario Tedesco; Simona Rosa; Pasquale Gramegna; Jacopo Ciaffi; Riccardo Meliconi; Maria Paola Landini; Giuseppe Filardo; Maria Pia Fantini; Stefano Zaffagnini
Journal:  Int J Environ Res Public Health       Date:  2021-05-13       Impact factor: 3.390

3.  Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience.

Authors:  Sonam Vijay; Nitin Bansal; Brijendra Kumar Rao; Balaji Veeraraghavan; Camilla Rodrigues; Chand Wattal; Jagdish Prasad Goyal; Karuna Tadepalli; Purva Mathur; Ramanathan Venkateswaran; Ramasubramanian Venkatasubramanian; Sagar Khadanga; Sanjay Bhattacharya; Sudipta Mukherjee; Sujata Baveja; Sujatha Sistla; Samiran Panda; Kamini Walia
Journal:  Infect Drug Resist       Date:  2021-05-24       Impact factor: 4.003

4.  Physical distancing and the perception of interpersonal distance in the COVID-19 crisis.

Authors:  Robin Welsch; Marlene Wessels; Christoph Bernhard; Sven Thönes; Christoph von Castell
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

5.  Comorbidity status of deceased COVID-19 in-patients in Italy.

Authors:  Davide Liborio Vetrano; Clare Tazzeo; Luigi Palmieri; Alessandra Marengoni; Alberto Zucchelli; Cinzia Lo Noce; Graziano Onder
Journal:  Aging Clin Exp Res       Date:  2021-06-24       Impact factor: 3.636

6.  Determinants of the willingness of the general population to get vaccinated against COVID-19 in a developing country.

Authors:  Abdel-Hameed Al-Mistarehi; Khalid A Kheirallah; Ahmed Yassin; Safwan Alomari; Maryam K Aledrisi; Ehab M Bani Ata; Nouran H Hammad; Asim N Khanfar; Ali M Ibnian; Basheer Y Khassawneh
Journal:  Clin Exp Vaccine Res       Date:  2021-05-31

7.  Face Mask Usage among Young Polish People during the COVID-19 Epidemic-An Evolving Scenario.

Authors:  Radomir Reszke; Marta Szepietowska; Piotr K Krajewski; Łukasz Matusiak; Rafał Białynicki-Birula; Jacek C Szepietowski
Journal:  Healthcare (Basel)       Date:  2021-05-27

Review 8.  Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly.

Authors:  Adel A Gomaa; Hamdy S Mohamed; Rasha Bakheet Abd-Ellatief; Mohamed A Gomaa
Journal:  Inflammopharmacology       Date:  2021-07-05       Impact factor: 4.473

9.  Multivariable mortality risk prediction using machine learning for COVID-19 patients at admission (AICOVID).

Authors:  Sujoy Kar; Rajesh Chawla; Sai Praveen Haranath; Suresh Ramasubban; Nagarajan Ramakrishnan; Raju Vaishya; Anupam Sibal; Sangita Reddy
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

Review 10.  Stopping the COVID-19 pandemic in dental offices: A review of SARS-CoV-2 transmission and cross-infection prevention.

Authors:  Maya Hartig; Carley Stephens; Aaron Foster; Douglas Fontes; Michael Kinzel; Franklin García-Godoy
Journal:  Exp Biol Med (Maywood)       Date:  2021-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.